@misc{indiciaea693b9fcc1fd,
  title = {The impact of EGFR subtype combined with TP53 co-mutation status on survival outcomes with front-line osimertinib in non-small cell lung cancer (NSCLC).},
  author = {Hye Sung Kim and Li Zhang and J Nicholas Bodor and Margie L Clapper and Hossein Borghaei and Martin J Edelman and Yunyun Zhou and Mitchell Cheung and Joseph Treat},
  year = {2026},
  doi = {10.1016/j.lungcan.2026.109582},
  url = {https://pubmed.ncbi.nlm.nih.gov/42660014/},
  note = {Source identifier: 42660014}
}